Universal Ibogaine Pink Sheet Forecast - Double Exponential Smoothing

IBOGF Stock  USD 0.01  0.0009  19.57%   
Universal Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Universal Ibogaine's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 26th of January 2026, The relative strength index (RSI) of Universal Ibogaine's share price is at 50. This usually indicates that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Universal Ibogaine, making its price go up or down.

Momentum 50

 Impartial

 
Oversold
 
Overbought
The successful prediction of Universal Ibogaine's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Universal Ibogaine and does not consider all of the tangible or intangible factors available from Universal Ibogaine's fundamental data. We analyze noise-free headlines and recent hype associated with Universal Ibogaine, which may create opportunities for some arbitrage if properly timed.
Using Universal Ibogaine hype-based prediction, you can estimate the value of Universal Ibogaine from the perspective of Universal Ibogaine response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Universal Ibogaine on the next trading day is expected to be 0 with a mean absolute deviation of 0.0007 and the sum of the absolute errors of 0.04.

Universal Ibogaine after-hype prediction price

    
  USD 0.007003  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Universal Ibogaine to cross-verify your projections.

Universal Ibogaine Additional Predictive Modules

Most predictive techniques to examine Universal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Universal using various technical indicators. When you analyze Universal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Universal Ibogaine works best with periods where there are trends or seasonality.

Universal Ibogaine Double Exponential Smoothing Price Forecast For the 27th of January

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Universal Ibogaine on the next trading day is expected to be 0 with a mean absolute deviation of 0.0007, mean absolute percentage error of 0.00000085, and the sum of the absolute errors of 0.04.
Please note that although there have been many attempts to predict Universal Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Universal Ibogaine's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Universal Ibogaine Pink Sheet Forecast Pattern

Backtest Universal Ibogaine  Universal Ibogaine Price Prediction  Buy or Sell Advice  

Universal Ibogaine Forecasted Value

In the context of forecasting Universal Ibogaine's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Universal Ibogaine's downside and upside margins for the forecasting period are 0.000055 and 22.58, respectively. We have considered Universal Ibogaine's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.01
0.000055
Downside
0
Expected Value
22.58
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Universal Ibogaine pink sheet data series using in forecasting. Note that when a statistical model is used to represent Universal Ibogaine pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 1.0E-4
MADMean absolute deviation7.0E-4
MAPEMean absolute percentage error0.156
SAESum of the absolute errors0.044
When Universal Ibogaine prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Universal Ibogaine trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Universal Ibogaine observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Universal Ibogaine

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universal Ibogaine. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0122.86
Details
Intrinsic
Valuation
LowRealHigh
0.000.0122.86
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Universal Ibogaine. Your research has to be compared to or analyzed against Universal Ibogaine's peers to derive any actionable benefits. When done correctly, Universal Ibogaine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Universal Ibogaine.

Universal Ibogaine After-Hype Price Density Analysis

As far as predicting the price of Universal Ibogaine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Universal Ibogaine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Universal Ibogaine, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Universal Ibogaine Estimiated After-Hype Price Volatility

In the context of predicting Universal Ibogaine's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Universal Ibogaine's historical news coverage. Universal Ibogaine's after-hype downside and upside margins for the prediction period are 0.00 and 22.86, respectively. We have considered Universal Ibogaine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.01
0.01
After-hype Price
22.86
Upside
Universal Ibogaine is out of control at this time. Analysis and calculation of next after-hype price of Universal Ibogaine is based on 3 months time horizon.

Universal Ibogaine Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Universal Ibogaine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universal Ibogaine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Universal Ibogaine, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.08 
22.58
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.01
0.01
27.32 
0.00  
Notes

Universal Ibogaine Hype Timeline

Universal Ibogaine is currently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Universal is forecasted to increase in value after the next headline, with the price projected to jump to 0.007003 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 27.32%, whereas the daily expected return is currently at 2.08%. The volatility of related hype on Universal Ibogaine is about 0.0%, with the expected price after the next announcement by competition of 0.01. Universal Ibogaine has accumulated 1.74 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. Universal Ibogaine has a current ratio of 2.35, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Universal Ibogaine until it has trouble settling it off, either with new capital or with free cash flow. So, Universal Ibogaine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Universal Ibogaine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Universal to invest in growth at high rates of return. When we think about Universal Ibogaine's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be uncertain.
Check out Historical Fundamental Analysis of Universal Ibogaine to cross-verify your projections.

Universal Ibogaine Related Hype Analysis

Having access to credible news sources related to Universal Ibogaine's direct competition is more important than ever and may enhance your ability to predict Universal Ibogaine's future price movements. Getting to know how Universal Ibogaine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Universal Ibogaine may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AGNPFAlgernon Pharmaceuticals 0.00 0 per month 0.00 (0.07) 14.10 (14.26) 31.25 
RNUGFReNeuron Group Plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
HESGHealth Sciences Gr 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ADXSAyala Pharmaceuticals 0.00 0 per month 23.07  0.23  122.19 (53.64) 734.55 
APLIFAppili Therapeutics 0.00 0 per month 7.38 (0.01) 20.00 (16.67) 42.48 
NMLSFNova Mentis Life 0.00 0 per month 5.72  0.12  17.30 (13.81) 66.40 
GRTXGalera Therapeutics 0.00 0 per month 5.80  0.08  14.89 (11.11) 60.42 
VGLSVg Life Sciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
AAGHAmerica Great Health 0.00 0 per month 0.00  0.05  0.00  0.00  150.00 
GENPFGenix Pharmaceuticals 0.00 0 per month 0.00  0.03  0.00  0.00  158.17 

Other Forecasting Options for Universal Ibogaine

For every potential investor in Universal, whether a beginner or expert, Universal Ibogaine's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Universal Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Universal. Basic forecasting techniques help filter out the noise by identifying Universal Ibogaine's price trends.

Universal Ibogaine Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Universal Ibogaine pink sheet to make a market-neutral strategy. Peer analysis of Universal Ibogaine could also be used in its relative valuation, which is a method of valuing Universal Ibogaine by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Universal Ibogaine Market Strength Events

Market strength indicators help investors to evaluate how Universal Ibogaine pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Universal Ibogaine shares will generate the highest return on investment. By undertsting and applying Universal Ibogaine pink sheet market strength indicators, traders can identify Universal Ibogaine entry and exit signals to maximize returns.

Universal Ibogaine Risk Indicators

The analysis of Universal Ibogaine's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Universal Ibogaine's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting universal pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Universal Ibogaine

The number of cover stories for Universal Ibogaine depends on current market conditions and Universal Ibogaine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Universal Ibogaine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Universal Ibogaine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Other Information on Investing in Universal Pink Sheet

Universal Ibogaine financial ratios help investors to determine whether Universal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Ibogaine security.